Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Hot Flashes 4Breast Neoplasms 3Prostatic Neoplasms 2Head and Neck Neoplasms 2Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Sleep Wake Disorders 1Lymphoma, Follicular 1Depressive Disorder, Major 1Depressive Disorder 1Depression 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Pain 1Breast Carcinoma In Situ 1Bipolar Disorder 1Adenocarcinoma 1

Interventions

Venlafaxine Hydrochloride 1Specimen Handling 1Psilocybin 1Interviews as Topic 1Dignity Therapy 1Counseling 1Antidepressive Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Depressive Disorder × Venlafaxine Hydrochloride × Clear all
NCT04977271 2025-02-04

Mood Disorders in Head and Neck Cancer Patients

University of Alabama at Birmingham

Phase 4 Withdrawn
Head & Neck

Depressive Disorder, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡